Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Qiagen NV (QGEN)
NYSE:QGEN
Earnings Data
Report Date
May 05, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.49Last Year’s EPS
0.47Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 05, 2025
|% Change Since: -11.94%
|Next Earnings Date:May 05, 2025
Earnings Call Sentiment|Positive
Qiagen N.V. delivered a strong performance in Q4 2024, exceeding expectations in net sales and adjusted earnings, with significant growth in key product segments and improved profitability. However, challenges remain in specific regions and market segments, with cautious market conditions and declines in certain areas such as the Asia Pacific Japan region and Sample Technologies. Overall, the achievements and growth initiatives position the company well for future growth, despite current challenges.Company Guidance
During the Qiagen N.V. Q4 2024 earnings call, the company reported strong financial performance, exceeding their outlook for both net sales and adjusted earnings. They achieved net sales of €521 million in Q4, marking a 3% growth at constant exchange rates (CER), and surpassed their goal of €520 million CER. The company's core business sales grew 4% CER, excluding discontinued products. Adjusted diluted EPS was $0.61 CER, exceeding the target of $0.60 CER. For the full year 2024, Qiagen exceeded their net sales outlook of €1.985 billion CER and adjusted EPS outlook of $2.19 CER. Key growth contributors included the KIAstat Diagnostics with 25% CER growth in Q4 and QuantiFERON with 14% growth in Q4. Qiagen also expanded their QIAcuity digital PCR platform and achieved a 63% increase in free cash flow to €506 million in 2024. The company announced a new synthetic share repurchase of approximately $300 million, reaffirming their commitment to returning at least $1 billion to shareholders by 2028. Looking forward, Qiagen expects net sales growth of approximately 4% CER and adjusted diluted EPS of at least $2.28 CER for 2025.Strong Performance and Outlook Exceeded
Qiagen N.V. exceeded its Q4 2024 outlook for both net sales and adjusted earnings, with net sales at €521 million, growing 3% CER, and adjusted diluted EPS at $0.61 CER, surpassing the target of at least $0.60 CER.
Record Growth in Key Segments
KIAstat Diagnostics saw 25% CER growth in Q4 2024, with over 616 new system placements. QuantiFERON achieved 14% growth in Q4 and 11% CER growth for the year.
Significant Improvements in Profitability
Adjusted operating income margin rose by 2.6 percentage points in Q4 2024 to 30.6% of sales. Free cash flow increased by 63% to €506 million in 2024 compared to 2023.
Successful Product Launches and FDA Clearances
FDA clearances were achieved for four panels for the KIAstat Dx syndromic testing system, and QIAcuity diagnostic capabilities were expanded for clinical use.
Commitment to Shareholder Returns
Qiagen N.V. completed a $300 million share repurchase early 2025, reaffirming its commitment to return at least $1 billion to shareholders by the end of 2028.
---
QGEN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
QGEN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 05, 2025 | $43.80 | $42.44 | -3.11% |
| Nov 06, 2024 | $43.86 | $44.14 | +0.64% |
| Jul 31, 2024 | $44.48 | $45.79 | +2.95% |
| Apr 29, 2024 | $42.29 | $42.32 | +0.07% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Qiagen NV (QGEN) report earnings?
Qiagen NV (QGEN) is schdueled to report earning on May 05, 2025, TBA Not Confirmed.
What is Qiagen NV (QGEN) earnings time?
Qiagen NV (QGEN) earnings time is at May 05, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is QGEN EPS forecast?
QGEN EPS forecast for the fiscal quarter 2025 (Q1) is 0.49.
---